Prelude Therapeutics Inc Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Prelude Therapeutics Inc quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Prelude Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was -66.9 %, a 24.1% decline year-over-year.
  • Prelude Therapeutics Inc annual Return On Equity for 2023 was -53.4 %, a 5.87% decline from 2022.
  • Prelude Therapeutics Inc annual Return On Equity for 2022 was -50.4 %, a 45.4% decline from 2021.
  • Prelude Therapeutics Inc annual Return On Equity for 2021 was -34.7 %, a 52.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -53.4 -2.96 -5.87% Jan 1, 2023 Dec 31, 2023
2022 -50.4 -15.8 -45.4% Jan 1, 2022 Dec 31, 2022
2021 -34.7 +38.2 +52.4% Jan 1, 2021 Dec 31, 2021
2020 -72.8 -146 -199% Jan 1, 2020 Dec 31, 2020
2019 73.4 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.